These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 9339107

  • 1. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns.
    Coşkun M, Kardelen F, Oygür N, Undar L, Savaş A, Yeğin O.
    Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107
    [Abstract] [Full Text] [Related]

  • 2. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J, Kim Y, Lim J, Kim M, Han K.
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E, Bason C, Visani G, Gobbi M, Ottaviani E, Ghio R.
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [Abstract] [Full Text] [Related]

  • 4. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G, Scambia G, Benedetti P, Menichella G, Testa U, Pierelli L, Martucci R, Foddai ML, Bizzi B, Mancuso S.
    Cancer Res; 1993 Mar 15; 53(6):1297-303. PubMed ID: 7680283
    [Abstract] [Full Text] [Related]

  • 5. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.
    Haematologica; 1999 Nov 15; 84(11):1016-23. PubMed ID: 10553163
    [Abstract] [Full Text] [Related]

  • 6. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 Nov 15; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors.
    Cetingül N, Kütükçüler N, Kantar M, Kavakli K, Nişli G, Cağlayan S, Oztop S.
    Turk J Pediatr; 1997 Nov 15; 39(4):473-81. PubMed ID: 9433149
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of serum granulocyte colony stimulating factor levels in infants of preeclamptic mothers.
    Güner S, Yiğit S, Cetin M, Kirazli S, Yurdakök M, Korkmaz A, Tekinalp G.
    Turk J Pediatr; 2007 Nov 15; 49(1):55-60. PubMed ID: 17479645
    [Abstract] [Full Text] [Related]

  • 9. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
    Conran N, Saad ST, Costa FF, Ikuta T.
    Ann Hematol; 2007 Apr 15; 86(4):255-61. PubMed ID: 17205286
    [Abstract] [Full Text] [Related]

  • 10. [Selected hematopoietic cytokines in patients with colorectal cancer].
    Mroczko B, Ławicki S, Szmitkowski M, Czygier M, Okulczyk B, Piotrowski Z.
    Pol Merkur Lekarski; 2003 Nov 15; 15(89):416-9. PubMed ID: 14969133
    [Abstract] [Full Text] [Related]

  • 11. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M.
    Pol Merkur Lekarski; 2007 Oct 15; 23(136):259-63. PubMed ID: 18293847
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G, Malamou-Mitsi V, Briasoulis E, Damala K, Vassou A, Vartholomatos G, Kolaitis N, Pavlidis N.
    Cancer; 2004 Oct 15; 101(8):1767-75. PubMed ID: 15386335
    [Abstract] [Full Text] [Related]

  • 14. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2009 Oct 15; 66(7):365-9. PubMed ID: 20043577
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar 15; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 18. Granulocyte-macrophage colony-stimulating factor suppresses induction of neutrophil alkaline phosphatase synthesis by granulocyte colony-stimulating factor.
    Teshima T, Shibuya T, Harada M, Akashi K, Taniguchi S, Okamura T, Niho Y.
    Exp Hematol; 1990 May 15; 18(4):316-21. PubMed ID: 1691103
    [Abstract] [Full Text] [Related]

  • 19. Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF.
    Zhang HH, Basu S, Wu F, Begley CG, Saris CJ, Dunn AR, Burgess AW, Walker F.
    J Leukoc Biol; 2007 Oct 15; 82(4):915-25. PubMed ID: 17652450
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.